Berita berkelanjutan · 1 laporan
Trump administration's ibogaine fast-track effort
Sedang berkembangPemeriksaan berikutnya : Whether the administration or FDA abandons the effort, or the FDA completes a decision on ibogaine’s development or approval pathway.
Perkembangan terkini
As of July 23, 2026, the Trump administration was pushing to fast-track ibogaine for addiction treatment, while experts cited cardiac risks linked to potentially fatal arrhythmias. The report identifies Trump and the FDA as decision-makers but gives no decision, next step or indication that the effort has been abandoned.
Pelacak beritaHari ke-1
1 laporan11 media11 sumber1 video
Perkembangan sejauh ini
Twenty-Seven Dead, No FDA Approval, and a Presidential Pen
Trump's April executive order fast-tracks ibogaine, a Schedule I psychedelic with documented cardiac risk, while Americans keep dying at unregulated clinics abroad.
Masih terbuka setelah laporan ini
- The full death toll at foreign clinics, including non-American patients, is not publicly tracked.
- How the FDA will interpret "expedite" — whether it fast-tracks a specific application or reopens the research pathway — has not been disclosed.
- Whether Texas's state-funded trials will produce randomized data sufficient for an FDA submission.
Riwayat
Dibuka1 laporan
Siapa yang terlibat
Tokoh
Céline GounderAmerican infectious disease physician, internist, epidemiologist, filmmaker, and medical journalist1 laporan
Donald TrumpPresident of the United States (2017–2021; since 2025)1 laporan
Joe RoganAmerican broadcaster, comedian, and actor (born 1967)1 laporan
Tempat
- MexicoMexico1 laporan
- Stanford University450 Jane Stanford Way, Stanford, CA 94305, USA1 laporan
- TexasTexas, USA1 laporan
- The Oval Office1600 Pennsylvania Ave NW, Washington, DC 20500, USA1 laporan
Semua media yang kami baca tentang berita ini
11 sumber11 media1 video
CBS Newscbsnews.com1
celinegounder.com1
HeyDay News11 video
modeldiplomat.com1
Newsweeknewsweek.com1
